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Abstract
Objective To assess the safety of using single complete compression
ultrasonography in pregnant and postpartum women to rule out deep
vein thrombosis.
Design Prospective outcome study.
Setting Two tertiary care centres and 18 private practices specialising
in vascular medicine in France and Switzerland.
Participants 226 pregnant and postpartum women referred for suspected
deep vein thrombosis.
Methods A single proximal and distal compression ultrasonography was
performed. All women with a negative complete compression
ultrasonography result did not receive anticoagulant therapy and were
followed up for a three month period.
Main outcome measures Symptoms of venous thromboembolism,
second compression ultrasonography or chest imaging, a
thromboembolic event, and anticoagulant treatment.
Results 16 women were excluded, mainly because of associated
suspected pulmonary embolism. Deep vein thrombosis was diagnosed
in 22 out of the 210 included women (10.5%). 10 patients received full
dose anticoagulation despite a negative test result during follow-up. Of
the 177 patients without deep vein thrombosis and who did not receive
full dose anticoagulant therapy, two (1.1%, 95% confidence interval 0.3%
to 4.0%) had an objectively confirmed deep vein thrombosis during
follow-up.
Conclusions The rate of venous thromboembolic events after single
complete compression ultrasonography in pregnant and postpartum
women seems to be within the range of that observed in studies in the
non-pregnant population. These data suggest that a negative single
complete compression ultrasonography result may safely exclude the
diagnosis of deep vein thrombosis in this setting.
Trial registration clinicaltrials.gov NCT00740454.
Introduction
Because pregnancy is known to be a risk factor for venous
thromboembolism and pregnant women often experience
symptoms compatible with deep vein thrombosis (pain,
tenderness, and swelling of the legs), the threshold for clinical
suspicionandtheaccuracyofclinicalexaminationarereduced.
1 2
Misdiagnoses during pregnancy, however, should be avoided
as much as possible—for example, false positive test results
lead to inappropriate anticoagulant treatment, which increases
theriskofbleedingandrequiresdailyheparininjectionsduring
the pregnancy. In contrast, false negative test results may lead
to a life threatening thromboembolic event. Thus the accuracy
of diagnostic methods used in pregnant women is crucial.
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Research
RESEARCHPhlebography remains the reference method for the diagnosis
of deep vein thrombosis,
3 but it is invasive and costly and
exposes the fetus to radiation. Serial impedance
plethysmography is the only non-invasive test that has been
formally proved, in a prospective study, to be safe during
pregnancy.
1 This test is no longer in use, however, mainly
because it has been shown to be less accurate than compression
ultrasonography in non-pregnant patients.
4 In such patients,
assessment of clinical probability combined with D-dimer
measurementisawellvalidatedstepforrulingoutdeepvenous
thrombosis. D-dimer levels, however, tend to increase steadily
with pregnancy stage and to decrease slowly during the first
weeks after delivery.
5 As a result, the clinical usefulness—that
is, the proportion of women with D-dimer levels below the
diagnostic cut-off—is reduced. Moreover, the safety of ruling
out deep vein thrombosis on the basis of D-dimer levels and
clinical probability has never been prospectively validated in
an outcome study of management during pregnancy.
In recent years, real time compression ultrasonography has
become the main diagnostic test for suspected deep vein
thrombosis.
6 In non-pregnant patients with suspected deep vein
thrombosis, a negative single complete compression
ultrasonography result allows the diagnosis to be safely ruled
out.
7 Indeed, the rate of thromboembolic events in the three
months after a negative single complete compression
ultrasonography result has been shown to be about 1%, a figure
comparabletothe1.3%(95%confidenceinterval0.3%to4.4%)
thromboembolic rate observed after a negative phlebography
test result.
3 8
Although compression ultrasonography is widely used, it has
notbeenprospectivelyevaluatedinpregnancyandpost-partum.
Its accuracy may be lower for several reasons. Firstly, pregnant
women often present with conditions that make visualisation
oftheveinsdifficult,suchaslegoedemaoragraviduterus,and
that interfere with the visualisation of the proximal veins.
Secondly, isolated iliac venous thromboses, which may be
encountered more often in pregnancy, are more difficult to be
diagnosed by compression ultrasonography, as the usual
accepted criterion for deep vein thrombosis—lack of
compressibilityoftheveins—maybedifficulttoevaluateatthe
iliaclevelinpregnantwomen.
9Thirdly,pregnancyisassociated
withchangesintheanatomyandphysiologyofveins—namely,
anincreasedvesseldiameterandreducedflowvelocity.
10These
physiological changes are associated with technical difficulties
for the ultrasound examination, and they persist for days or
weeks after delivery.
Nevertheless, a retrospective study suggested that single
completecompressionultrasonographymaysafelyexcludedeep
vein thrombosis during pregnancy and post partum.
11 We
assessed the safety of ruling out the diagnosis of deep vein
thrombosisinpregnantorearlypostpartumwomenusingsingle
compression ultrasonography.
Methods
We included all pregnant or postpartum women referred with
suspected deep vein thrombosis to two tertiary care centres and
18 private practices specialising in vascular medicine between
January 2006 and June 2009. Pregnancy had to have been
confirmed by the treating gynaecologist. Postpartum women
were considered for inclusion until three months after delivery.
Exclusion criteria were age less than 18 years, associated
suspected pulmonary embolism, ongoing anticoagulant
treatment, inability to give informed consent, and difficulties
with follow-up.
Standardised report forms were filled in for all patients,
recording general characteristics (age, date of delivery, end of
pregnancy,height,weight,andweightgain)andriskfactorsfor
venousthromboembolism,includingpersonalandfamilyhistory
of venous thromboembolic disease, recent surgery, trauma or
immobilisation, history of varicose veins, complicated or twin
pregnancy. Doctors were asked to empirically estimate the
pretest clinical probability of deep vein thrombosis in three
groups (low, intermediate, and high), although this had no
impact on patient management.
Venous ultrasonography
WeusedhighdefinitionBmodeultrasoundimagingequipment,
with different probes according to the depth of the examined
vessels. Iliac veins were visualised by direct imaging and
Doppler flow. The whole venous network was scanned
bilaterally:theinferiorvenacavaandiliacveinswiththepatient
supine or in the contralateral position, femoral veins (common,
superficial)andpoplitealveinswiththepatientinasemi-upright
position, and calf veins (posterior tibial and peroneal) with the
patient in a sitting position and both feet resting on a chair.
12 13
Study of the distal veins included the posterior tibial and
peroneal veins, the gastrocnemius (internal and external), and
the soleal veins, using different incidences. All of these venous
segments were examined over their entire length in the
transverse or longitudinal axis. The great and small saphenous
veins were also studied at their junctions with the deep venous
system.Specialattentionwaspaidtowhetherdoctorswereable
to image all veins, in particular the ileocaval junction. All
ultrasound examinations were performed by vascular medicine
specialists with at least 10 years of experience in vascular
ultrasound imaging.
Diagnostic criteria
We ruled out deep vein thrombosis in women with a negative
compression ultrasonography test result and no visualised
thrombus. Deep vein thrombosis was diagnosed with lack of
compressibility of a deep vein and, for the iliac vein, in the
absence of Doppler flow or direct visualisation of a thrombus.
Follow-up
Wefollowedupallwomenwithnegativecompletecompression
ultrasonographytestresultsforathreemonthperiod.Attheend
of follow-up, the women were seen at the clinic or interviewed
by telephone by the study staff using a standardised
questionnairetogatherinformationaboutthethreemonthperiod
after compression ultrasonography: the women were asked if
they had symptoms suggestive of venous thromboembolism,
had undergone a second compression ultrasonography or chest
imaging (computed tomography, ventilation-perfusion lung
scan), had a diagnosis of deep vein thrombosis, or been treated
with anticoagulant therapy. We excluded from analysis those
womenwhoreceivedprolongedanticoagulanttreatmentduring
follow-up as this could bias the rate of recurrent deep vein
thrombosisduringfollow-up.Wealsocheckedtheparticipants’
hospital medical records. When women could not be reached,
adoctorfromourresearchteamcalledtheirgeneralpractitioner
tocompletefollow-up.Incaseofasuspectedevent,wecollected
clinicalnotesandtheresultsofdiagnostictestsforadjudication.
All suspected events were independently adjudicated by two
expert doctors. A third doctor adjudicated discrepancies.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e2635 doi: 10.1136/bmj.e2635 (Published 24 April 2012) Page 2 of 9
RESEARCHStatistical analysis
The three month thromboembolic rate after a normal
phlebography result in non-pregnant patients has been reported
to be 1.3% (95% confidence interval 0.3% to 4.4%). We
estimated that we had to obtain a complete follow-up in 180
women with a negative compression ultrasonography result to
ensure that the upper limit of the 95% confidence interval was
not higher than 4.0% around a 1.0% proportion of
thromboembolic events during the three-month follow-up in
women left untreated after a negative test result.
We computed the proportion of thromboembolic events during
the three month period in women after a negative test result,
alongwith95%confidenceintervals.Usingaχ
2testorFisher’s
exact test where applicable we estimated and tested the
differenceintheproportionofwomenwithconfirmeddeepvein
thrombosis according to stage of pregnancy, which leg had
suspected deep vein thrombosis, and the clinical probability
group.
Results
Overall, 226 pregnant or postpartum women with suspected
deep vein thrombosis were included (figure⇓). Sixteen were
excluded: 14 because of a concomitant suspicion of pulmonary
embolism and two because compression ultrasonography was
performed as a routine test for follow-up of a previous deep
vein thrombosis. Thus the final sample comprised 210 women.
Table 1⇓ shows the general characteristics of the women. The
medianagewas33(interquartilerange28-37)years.Fortythree
women were in the postpartum period and 167 were pregnant:
20 in the first trimester, 51 in the second, and 96 in the third.
In postpartum women, deep vein thrombosis was suspected
after a median period of 5 (3-26) days. The pretest clinical
probability was deemed low in 107 (50.9%) women,
intermediate in 85 (40.5%), and high in 18 (8.6%).
Deep vein thrombosis was diagnosed in 22 women. Of these,
20 (91%) had a proximal (iliac, femoral, or popliteal) deep vein
thrombosis,ofwhomfouralsohadadistaldeepveinthrombosis
and one had a superficial vein thrombosis. The two remaining
women had an isolated distal deep vein thrombosis. Thus the
overall proportion of women with confirmed deep vein
thrombosis was 10.5% (22/210). Of the 22 women with a
diagnosis of deep vein thromboses, the left leg was involved in
18 (82%). The proportion of women with deep vein thrombosis
according to pregnancy stage was: 4 (18.2%) during the first
trimester, 1 (4.5%) during the second, 9 (40.9%) during the
third, and 8 (36.4%) during the postpartum period. Deep vein
thrombosiswasdiagnosedonthebasisofapositivecompression
ultrasonographytestresultinallbutonewoman.Inthiswoman
the diagnosis was made on the basis of the absence of Doppler
flow in the iliac vein, with a “sludge” aspect in the common
femoral vein. The diagnosis was formally confirmed two days
later by a positive test result on repeated compression
ultrasonography, with visualised endoluminal material.
Theproportionofwomenwithconfirmeddeepveinthrombosis
differed significantly according to the trimester, the suspected
affected leg, and the pretest clinical probability group (table
2⇓). Deep vein thrombosis was confirmed in 16% of women in
whom it was suspected in the left leg and 4.5% in whom it was
suspectedintheright,andinnowomenwithbilateralsymptoms.
The association between empirical assessment of clinical
probability and the proportion of women with confirmed deep
veinthrombosiswasstrong:2/107(1.9%)inthelowprobability
group,7/85(8.2%)intheintermediategroup,and13/18(72.2%)
in the high group (P<0.001).
Other ultrasonographic findings
The ileocaval junction could not be imaged in 88 (41.9%)
women. Moreover, common iliac veins could not be imaged in
8 (3.8%), all iliac veins in 9 (4.3%), and popliteal veins in 1
(0.5%). Among the 188 women in whom the diagnosis of deep
vein thrombosis was excluded, an alternative diagnosis was
made by ultrasonography in 26: 21 had isolated superficial
thrombophlebitis, two had popliteal cysts, and one each had
muscular tear, tendinitis, and painful inguinal adenopathy.
Follow-up
Of the 188 women with no deep vein thrombosis at initial
examination, 10 received six weeks or more of anticoagulant
treatment in the therapeutic range, mainly for the treatment of
a superficial thrombophlebitis diagnosed at initial compression
ultrasonography(n=8).Onewomanwasstartedonanticoagulant
therapy by her doctor because of the discovery of a persistent
foramenovale,andanotherbecauseofahistoryoftwoprevious
deep vein thromboses in the presence of antiphospholipid
antibodies. These 10 women were excluded from further
analysis.Threeotherpatientsreceivedanticoagulationofshorter
duration for the treatment of a superficial thrombophlebitis (7,
8,and10days)andwerekeptinthemainanalysis.Onewoman
was lost to follow-up. No patient died during follow-up. Thus,
177 women were available for analysis. During follow-up, no
systematic serial compression ultrasonography was scheduled.
Seven patients had diagnostic tests ordered by their treating
doctors for clinically suspected venous thromboembolism. Six
women had suspected deep vein thrombosis (all ipsilateral to
the initial suspicion) and one had suspected pulmonary
embolism.Allthesesevenwomenunderwentnewcompression
ultrasonography and the patient with suspected pulmonary
embolism also underwent a ventilation-perfusion lung scan. In
four women with a suspected deep vein thrombosis, the
compression ultrasonography result was negative, the women
were left untreated, and a further three month follow-up was
uneventful. The patient with suspected pulmonary embolism
was admitted 50 days after the initial suspicion with fever and
pleuritic chest pain. Both the compression ultrasonography and
the ventilation-perfusion scan were interpreted as normal, and
the final diagnosis was acute pneumonia. She received no
anticoagulant therapy and further follow-up at three month was
uneventful. These five women were adjudicated as having no
recurrentvenousthromboembolism.Twowomenhadapositive
compression ultrasonography result, showing proximal deep
vein thrombosis during follow-up, and were adjudicated as
having a confirmed proximal deep vein thrombosis. There was
no disagreement between the two independent adjudicators.
Thus the three month thromboembolic rate in patients left
untreatedonthebasisofanegativesinglecompletecompression
ultrasonography result was 2/177 (1.1%, 95% confidence
interval 0.3% to 4.0%), in pregnant women was 2/145 (1.4%,
0.4%to4.9%)andinpostpartumwomenwas0/32(0.0%,0.0%
to 10.7%). Table 3⇓ summarises the medical history of the two
womenwhoexperiencedvenousthromboembolicdiseaseduring
follow-up.
Discussion
Inthisprospectivemanagementstudy,weincluded226pregnant
and postpartum women with suspected lower limb deep vein
thrombosis.Weobserveda1.1%(95%confidenceinterval0.3%
to 4.0%) three month thromboembolic event rate in those left
untreatedonthebasisofanegativesinglecompletecompression
ultrasonography result. This result is in line with what was
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RESEARCHreported after a normal phlebography—the reference test—in
non-pregnant patients
3 and with the data obtained in a
retrospective cohort study assessing the safety of a single
complete compression ultrasonography in pregnant and
postpartum women with suspected deep vein thrombosis.
11
Invenousthromboembolismmanagementoutcomestudies,the
occurrence of thromboembolic events during follow-up is
considered as a failure of the initial diagnostic strategy.
Admittedly,the4%upperboundofthe95%confidenceinterval
of the three month thromboembolic event rate in our study is
slightly higher than the 3% limit proposed by some authors.
14
Although this study is one of the largest available studies in the
settingofpregnantandpostpartumwomen,thesamplesizewas
relatively small, which could explain the wide confidence
interval. The 4% upper bound we observed is in line with the
results of a previous management outcome study in pregnant
women, which reported a three month venous thromboembolis
risk of 1/137 after negative serial proximal compression
ultrasonographyresults—thatis,ariskof0.7%(95%confidence
interval 0.4% to 4.0%).
15 However, we cannot exclude that
diagnostic exclusion on the basis of a single complete
compression ultrasonography result has a higher failure rate
than diagnostic strategies for deep vein thrombosis in
non-pregnant patients. If possible, larger studies should be
conducted to provide narrower estimates of this failure rate. An
increased risk of venous thromboembolic disease during
pregnancy and the postpartum period could also partly account
for the upper bound of our 95% confidence interval.
Nevertheless,itshouldbenotedthatamongthetwoadjudicated
events during follow-up, only one (patient A, table 3) clearly
represents a failure of initial compression ultrasonography.
PatientB(table3)couldaswellrepresentadenovothrombotic
episode. Indeed, this patient was admitted to hospital for
pre-term labour. Fifteen days after admission, she presented
with a swollen left leg and underwent her first compression
ultrasonography. Ten days later she developed pre-eclampsia
and underwent emergency caesarean section. She stayed
immobilised in bed until postoperative day 5, when she
mentionedanovellegpainandoedema.Repeatedcompression
ultrasonography showed a proximal deep vein thrombosis.
Several other results deserve further discussion. Firstly, the
prevalence of deep vein thrombosis in our study was 10.5%,
whichislowerthanusuallyobservedinvenousthromboembolic
diagnostic studies in Europe.
16 However, the proportion of
confirmed venous thromboembolic disease is usually lower in
pregnant women, which has been related to a lower threshold
for clinical suspicion.
15 17 The lower prevalence, as well as the
proportion of women with deep vein thrombosis in the left leg
and the rate of confirmed deep vein thrombosis during the first
trimester, are in line with a recent study.
18 Also, we observed
that almost 40% of deep vein thromboses occurred during the
postpartum period, in line with another previous report.
19
Secondly,mostdeepveinthrombosesinourstudywerelocated
in the proximal veins, as only two patients presented with
isolateddistaldeepveinthrombosis.Thismaysupportthechoice
of a diagnostic strategy based on single complete compression
ultrasonography in pregnant and postpartum women. Indeed,
two recent prospective studies comparing single complete
compressionultrasonographywithserialproximalcompression
ultrasonography suggested that both strategies have similar
safetyinnon-pregnantpatients.
20 21Inthesestudies,performing
single complete compression ultrasonography seemed more
convenient since it avoided repeated compression
ultrasonography, but at the expense of a significant increase in
theproportionofpatientsinwhomadistaldeepveinthrombosis
wasdiagnosed.Thisconcernaboutover-diagnosisofdeepvein
thrombosisseemstobelessrelevantinpregnantandpostpartum
women because according to our data, only 10% of deep vein
thrombosesaredistalinthispopulation,comparedwiththe52%
reported in non-pregnant patients in a recent meta-analysis of
diagnostic studies using complete compression
ultrasonography.
22
Thirdly, the diagnostic performance of clinical signs and
symptomsisalteredduringpregnancybecausepregnantwomen
often experience symptoms compatible with deep vein
thrombosis, and symptoms of deep vein thrombosis may vary
during pregnancy.
9 In our study, the assessment of clinical
probability had no influence on the diagnostic strategy.
Nevertheless, our data suggest that the empirical assessment of
clinical probability remains accurate in this context. A strong
associationwasfoundbetweenempiricalassessmentofclinical
probability and the proportion of confirmed deep vein
thrombosis: 2/107 (1.9%), in the low clinical probability class,
7/85 (8.2%) in the intermediate probability class, and 13/18
(72.2%), in the high clinical probability class. The two
thromboemboliceventsduringthefollow-upoccurredinpatients
not assessed as having a high clinical probability. Therefore,
this stratification could nothavebeenused toselectpatientsfor
a more intensive diagnostic strategy. Anyhow, the lack of
standardiz]sation and reproducibility of empirical assessment
makes the validation and use of clinical prediction rules such
as the recently derived LEFt (Left leg symptoms, Edema, First
trimester presentation) score highly appealing.
18
Limitations of the study
We chose to include pregnant women as well as postpartum
women. This might be regarded as a limitation of our study.
However, the technical limitations of ultrasound examination
persist during the first days and weeks after delivery. For this
reason it was important to check the safety of compression
ultrasonography during this period. Noteably, most of our
suspicionsduringthepostpartumperiodoccurredearly:median
5 (interquartile range 3-26) days.
Currentdiagnosticstrategiesforsuspecteddeepveinthrombosis
in non-pregnant patients rely on the use of clinical probability
and D-Dimer before the leg veins are imaged. We did not
include this step in our investigations. Indeed, neither a
management outcome study on the safety and usefulness of
D-Dimer to rule out deep vein thrombosis in pregnant women,
nor a validated clinical prediction rule in this setting, are
available to date. Future studies may validate the use of a
sequentialdiagnosticstrategyinpregnantwomenwithsuspected
deepveinthrombosisincludingtheLEFtscore,andtheD-Dimer
test,attheconventional500μg/Lcut-off,oratacut-offadjusted
for pregnancy stage, as recently described.
23
Finally,ourstudywasamanagementoutcomestudy.Admittedly
this study design did not allow us to estimate either the exact
numberofpatientswithfalsenegativeandfalsepositiveresults
or the conventional accuracy indices (sensitivity, specificity,
negative and positive predictive values) owing to the absence
of a gold standard test. However, this study design is a crucial
step in the validation of diagnostic strategies since it allows the
clinicalsafetyofadiagnosticstrategytobeassessed.Thisdesign
has been widely used in the past decades to validate all current
diagnostic strategies for venous thromboembolic disease.
24 25
Conclusion
The diagnosis of deep vein thrombosis during pregnancy is a
diagnostic challenge. The low prevalence of deep vein
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RESEARCHthrombosis and the need for a non-radiating diagnostic strategy
in these women render non-invasive diagnostic tools such as
compressionultrasonographyhighlyappealing.Ourstudyshows
thatsinglecompletecompressionultrasonographymightsafely
rule out the diagnosis of deep vein thrombosis in pregnant and
postpartum women. However, the limitations described above
aswellastheupperlimitofthe95%confidenceintervalaround
our estimate of the three month risk of a thromboembolic event
preventusfromdrawingfirmconclusions.Furtherinvestigations
should aim at confirming these results and evaluating the use
of compression ultrasonography in a sequential diagnostic
strategyincludingassessmentofclinicalprobabilityandD-dimer
measurement.
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RESEARCHWhat is already known on this topic
Single complete compression ultrasonography is widely used to rule out deep vein thrombosis in everyday clinical practice
No data are available to support this finding in the setting of pregnancy and the postpartum period
What this study adds
Single complete compression ultrasonography may safely rule out deep vein thrombosis in pregnant and postpartum women
Of 177 women without deep vein thrombosis and who did not receive full dose anticoagulant therapy, two experienced an objectively
confirmed deep vein thrombosis during follow-up
Tables
Table 1| General characteristics of pregnant and postpartum women with suspected deep vein thrombosis. Values are numbers (percentages)
unless stated otherwise
Total Characteristics
33 (28-37) Age (interquartile range) years
24.3 (21.5-27.5) Body mass index (interquartile range)
9 (5-13) Weight gain (interquartile range) kg
Stage of pregnancy:
20 (11.0) First trimester
51 (24.3) Second trimester
96 (45.7) Third trimester
43 (20.5) Post partum
Risk factors:
26 (12.4) Personal history of VTE
46 (21.9) Family history of VTE
10 (4.8) Known thrombophilia
25 (11.9) Recent immobilisation
6 (2.9) Recent surgery or trauma
57 (27.1) Varicose veins
17 (8.1) Complicated pregnancy*
6 (2.9) Twin pregnancy
12 (5.7) Recent travel (>6 hours)
VTE=venous thromboembolism.
*Encompassed gestational diabetes (n=6), preterm labour (n=4), intrauterine growth restriction (n=2), pre-eclampsia (n=2), placenta praevia (n=1), and ovarian
hyperstimulation syndrome (n=1).
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RESEARCHTable 2| Proportion of women with confirmed deep vein thrombosis according to pregnancy trimester, suspected affected leg, and clinical
probability of having deep vein thrombosis
P value* No with deep vein thrombosis/No in group (%) Variables
Pregnancy trimester:
0.03 4/20 (20.0) First
1/51 (2.0) Second
9/96 (9.4) Third
8/43 (18.6) Post partum
Suspected leg:
0.02 4/88 (4.5) Right
18/112 (16.1) Left
0/10 (0.0) Both legs
Clinical probability:
<0.001 2/107 (1.9) Low
7/85 (8.2) Intermediate
13/18 (72.2) High
*χ
2 test, or Fisher’s exact test where applicable.
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RESEARCHTable 3| Summary of medical history of two women adjudicated as having proximal deep vein thrombosis during three month follow-up
Patient B Patient A Variables
23 25 Age (years)
21.9 27.3 Body mass index
29 34 Stage of pregnancy (weeks)
0 0 Risk factors
Clinical probability of deep vein thrombosis:
Low
Yes Yes Intermediate
High
Initial compression ultrasonography:
Yes Yes All venous segments imaged
Yes Yes Ileocaval junction imaged
No Yes Respiratory modulation of iliac blood flow
Normal Normal Compression ultrasonography result
Compression ultrasonography during follow-up:
Day 15 Day 1 Date
Left iliofemoral deep vein thrombosis Left iliofemoral deep vein thrombosis Result
Was admitted for premature labour 15 days before initial
suspicion. Emergency caesarean section carried out five
days after initial suspicion. Suspected deep vein thrombosis
confirmed by compression ultrasonography on postoperative
day 5
Returned to emergency unit next day because of
increasing symptoms. Compression ultrasonography
result was clearly positive for deep vein thrombosis
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RESEARCHFigure
Flow of participants through study
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